Undisclosed
Exclusive Financial Advisor
Sale to Strides Pharma Science Limited
January 2019
$173 Million
Joint Book-Running Manager
Follow-On
January 2019
$265 Million
Joint Bookrunner
Follow-On
January 2019
$40 Million
Sole Bookrunner
Follow-On
December 2018
$45 Million
Joint Bookrunner
Follow-On
December 2018
$30 Million
Joint Bookrunner
Follow-On
December 2018
$125M + 1M Shares
Exclusive Financial Advisor
Acquisition of Genoptix
December 2018
$151 Million
Joint Bookrunner
Initial Public Offering
December 2018
$100 Million
Joint Bookrunner
Follow-On
December 2018
$850 Million
Joint Bookrunner
Convertible Senior Notes
November 2018
Undisclosed
Exclusive Financial Advisor
Sale to Convey Health Solutions, a Portfolio Company of NMC
November 2018
$80 Million
Exclusive Financial Advisor
Sale of Priority Review Voucher to Eli Lilly
October 2018